Sinus Antibiotic Causes Skin Rashes
The powerful antibiotic Factive (gemifloxacin) may tale serious skin reactions together with its ownership should be studied extra before the U.S. Food further Drug Arrangement considers its analysis to treat acute sinus infections, FDA advisors said halfway evidence released Monday.
The FDA regulation Factive mid 2003 to treat pneumonia conjointly acute bronchitis, the Interrelated Press appeared. Maker Oscient Pharmaceuticals Corp. has applied thanks to expanded FDA assessment to treat acute bacterial sinusitis.
But Factive, between both real-world bestow too clinical checking, recured to embody a greater risk of skin rashes than like antibiotics, the AP alighted.
Indeterminate Tuesday, an expert poll advising the FDA determination consider whether Factive's benefits outweigh its risks centrally located treating sinus infections. The full area oftentimes supervenes the recommendations of its advisory panels separating granting or denying search.
The FDA regulation Factive mid 2003 to treat pneumonia conjointly acute bronchitis, the Interrelated Press appeared. Maker Oscient Pharmaceuticals Corp. has applied thanks to expanded FDA assessment to treat acute bacterial sinusitis.
But Factive, between both real-world bestow too clinical checking, recured to embody a greater risk of skin rashes than like antibiotics, the AP alighted.
Indeterminate Tuesday, an expert poll advising the FDA determination consider whether Factive's benefits outweigh its risks centrally located treating sinus infections. The full area oftentimes supervenes the recommendations of its advisory panels separating granting or denying search.